Emerging role of C5aR2: novel insights into the regulation of uterine immune cells during pregnancy

Front Immunol. 2024 Jun 20:15:1411315. doi: 10.3389/fimmu.2024.1411315. eCollection 2024.

Abstract

Pregnancy is a fascinating immunological phenomenon because it allows allogeneic fetal and placental tissues to survive inside the mother. As a component of innate immunity with high inflammatory potential, the complement system must be tightly regulated during pregnancy. Dysregulation of the complement system plays a role in pregnancy complications including pre-eclampsia and intrauterine growth restriction. Complement components are also used as biomarkers for pregnancy complications. However, the mechanisms of detrimental role of complement in pregnancy is poorly understood. C5a is the most potent anaphylatoxin and generates multiple immune reactions via two transmembrane receptors, C5aR1 and C5aR2. C5aR1 is pro-inflammatory, but the role of C5aR2 remains largely elusive. Interestingly, murine NK cells have been shown to express C5aR2 without the usual co-expression of C5aR1. Furthermore, C5aR2 appears to regulate IFN-γ production by NK cells in vitro. As IFN-γ produced by uterine NK cells is one of the major factors for the successful development of a vital pregnancy, we investigated the role anaphylatoxin C5a and its receptors in the establishment of pregnancy and the regulation of uterine NK cells by examinations of murine C5ar2-/- pregnancies and human placental samples. C5ar2-/- mice have significantly reduced numbers of implantation sites and a maternal C5aR2 deficiency results in increased IL-12, IL-18 and IFN-γ mRNA expression as well as reduced uNK cell infiltration at the maternal-fetal interface. Human decidual leukocytes have similar C5a receptor expression patterns showing clinical relevance. In conclusion, this study identifies C5aR2 as a key contributor to dNK infiltration and pregnancy success.

Keywords: C5aR2; INF-γ; anaphylatoxins; pregnancy; uterine DCs; uterine NK cells.

MeSH terms

  • Animals
  • Complement C5a / immunology
  • Complement C5a / metabolism
  • Female
  • Humans
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism
  • Killer Cells, Natural* / immunology
  • Killer Cells, Natural* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout*
  • Placenta / immunology
  • Placenta / metabolism
  • Pregnancy
  • Receptor, Anaphylatoxin C5a* / genetics
  • Receptor, Anaphylatoxin C5a* / metabolism
  • Uterus* / immunology

Substances

  • Receptor, Anaphylatoxin C5a
  • C5ar2 protein, mouse
  • Complement C5a
  • C5aR2 protein, human
  • Interferon-gamma

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Deutsche Forschungsgemeinschaft through IRTG 1911 “Immune regulation of inflammation in allergy and infection”, project B2. In addition, the publication of this article was financially supported by the Land Schleswig-Holstein through the Open Access Publikationsfonds.